Related Experiment Video
Updated: Aug 19, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Kurarinone isolated from Sophora flavescens Ait inhibited MCP-1-induced chemotaxis
Seung Woong Lee1, Hyun Sun Lee, Jung Yeon Nam
1Laboratory of Lipid Metabolism, Korea Research Institute of Bioscience and Biotechnology, 52 Eoun-dong, Taejeon 305-333, Republic of Korea.
Abstract:
The accumulation of circulating monocytes in the arterial wall is an early in atherosclerotic plaque formation. Monocyte chemoattractant protein-1 (MCP-1) promotes the migration of monocytes and would play a role in the development of atherosclerotic lesions. Searching for inhibitors of MCP-1-induced cell migration from natural sources, we isolated one active compound through active-guided fractionations from the MeOH extracts of Sophora flavescens Ait (Leguminosae). On the basis of spectral evidence, the structure of active compound was identified as kurarinone. It inhibited the migration of THP-1 cells induced by MCP-1 with IC50 value of 19.2 microg/mL. In addition, it inhibited the binding of MCP-1 to THP-1 cells and phosphorylation of p42/44 MARK.
Insights
Kurarinone, isolated from Sophora flavescens, effectively inhibits monocyte migration, a key factor in atherosclerosis development. This natural compound also blocks MCP-1 binding and related cell signaling pathways.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Cardiovascular Research
Background:
- Monocyte accumulation in arterial walls is an early event in atherosclerotic plaque formation.
- Monocyte chemoattractant protein-1 (MCP-1) drives monocyte migration, contributing to atherosclerotic lesion development.
Purpose of the Study:
- To identify natural inhibitors of MCP-1-induced monocyte migration.
- To investigate the anti-atherosclerotic potential of compounds from Sophora flavescens.
Main Methods:
- Active-guided fractionation of MeOH extracts from Sophora flavescens Ait.
- Structural identification of the active compound using spectral evidence.
- Assay of THP-1 cell migration inhibition induced by MCP-1.
- Evaluation of MCP-1 binding to THP-1 cells and p42/44 MARK phosphorylation.
Main Results:
- Kurarinone was isolated and identified as the active compound.
- Kurarinone inhibited MCP-1-induced THP-1 cell migration with an IC50 of 19.2 microg/mL.
- Kurarinone demonstrated inhibition of MCP-1 binding and p42/44 MARK phosphorylation.
Conclusions:
- Kurarinone is a novel inhibitor of MCP-1-induced monocyte migration.
- Kurarinone possesses potential therapeutic value for preventing or treating atherosclerosis.
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Cancer Cell Migration through Invadopodia

